Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
175.87
+2.30 (1.33%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Quest Diagnostics Employees
Quest Diagnostics had 56,000 employees as of December 31, 2024. The number of employees increased by 8,000 or 16.67% compared to the previous year.
Employees
56,000
Change (1Y)
8,000
Growth (1Y)
16.67%
Revenue / Employee
$181,393
Profits / Employee
$15,929
Market Cap
19.63B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 56,000 | 8,000 | 16.67% |
Dec 31, 2023 | 48,000 | -1,000 | -2.04% |
Dec 31, 2022 | 49,000 | 0 | - |
Dec 31, 2021 | 49,000 | 0 | - |
Dec 31, 2020 | 49,000 | 2,000 | 4.26% |
Dec 31, 2019 | 47,000 | 1,000 | 2.17% |
Dec 31, 2018 | 46,000 | 1,000 | 2.22% |
Dec 31, 2017 | 45,000 | 2,000 | 4.65% |
Dec 31, 2016 | 43,000 | -1,000 | -2.27% |
Dec 31, 2015 | 44,000 | -1,000 | -2.22% |
Dec 31, 2014 | 45,000 | 4,000 | 9.76% |
Dec 31, 2013 | 41,000 | 0 | - |
Dec 31, 2012 | 41,000 | -1,000 | -2.38% |
Dec 31, 2011 | 42,000 | 0 | - |
Dec 31, 2010 | 42,000 | -1,000 | -2.33% |
Dec 31, 2009 | 43,000 | 200 | 0.47% |
Dec 31, 2008 | 42,800 | -700 | -1.61% |
Dec 31, 2007 | 43,500 | 2,500 | 6.10% |
Dec 31, 2006 | 41,000 | -500 | -1.20% |
Dec 31, 2005 | 41,500 | 2,900 | 7.51% |
Dec 31, 2004 | 38,600 | 1,400 | 3.76% |
Dec 31, 2003 | 37,200 | 3,800 | 11.38% |
Dec 31, 2002 | 33,400 | 4,400 | 15.17% |
Dec 31, 2001 | 29,000 | 2,000 | 7.41% |
Dec 31, 2000 | 27,000 | 0 | - |
Dec 31, 1999 | 27,000 | 12,000 | 80.00% |
Dec 31, 1998 | 15,000 | -1,300 | -7.98% |
Dec 31, 1997 | 16,300 | -1,500 | -8.43% |
Dec 31, 1996 | 17,800 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
DGX News
- 1 day ago - These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Q1 Earnings - Benzinga
- 2 days ago - Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence - Benzinga
- 2 days ago - Quest Diagnostics Incorporated (DGX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - Quest beats quarterly profit estimates on strong demand for diagnostic tests - Reuters
- 2 days ago - Quest Diagnostics earnings beat after March rebound in demand from slump early in the quarter - Market Watch
- 2 days ago - Quest Diagnostics Reports First Quarter 2025 Financial Results; Reaffirms Revenue and Adjusted Diluted EPS Guidance for Full Year 2025 - PRNewsWire
- 15 days ago - Quest Diagnostics Launches New AD-Detect™ Blood Test to Aid in Confirming Alzheimer's Disease - PRNewsWire
- 20 days ago - 8 Upcoming Dividend Increases During Volatile Times - Seeking Alpha